| The diagnosis and management of Cushing's syndrome in pregnancy R Hamblin, A Coulden, A Fountas, N Karavitaki Journal of neuroendocrinology 34 (8), e13118, 2022 | 29 | 2022 |
| Risk of second brain tumour after radiotherapy for pituitary adenoma or craniopharyngioma: a retrospective, multicentre, cohort study of 3679 patients with long-term imaging … R Hamblin, A Vardon, J Akpalu, M Tampourlou, I Spiliotis, E Sbardella, ... The Lancet Diabetes & Endocrinology 10 (8), 581-588, 2022 | 28 | 2022 |
| Cardiovascular health and mortality in Cushing’s disease A Coulden, R Hamblin, J Wass, N Karavitaki Pituitary 25 (5), 750-753, 2022 | 21 | 2022 |
| Craniopharyngiomas R Hamblin, G Tsermoulas, N Karavitaki La Presse Médicale 50 (4), 104078, 2021 | 13 | 2021 |
| Craniopharyngiomas K Lithgow, R Hamblin, U Pohl, N Karavitaki Endotext [Internet], 2022 | 12 | 2022 |
| Natural history of non-functioning pituitary microadenomas: results from the UK non-functioning pituitary adenoma consortium R Hamblin, A Fountas, K Lithgow, PB Loughrey, E Bonanos, SK Shinwari, ... European Journal of Endocrinology 189 (1), 87-95, 2023 | 9 | 2023 |
| Impulse control disorders in patients with pituitary tumors treated with dopamine agonists: a systematic review R Hamblin, N Karavitaki Archives of Medical Research, 102910, 2023 | 4 | 2023 |
| Multidisciplinary team perspective: A model of care for patients with pituitary tumors A Fountas, R Hamblin, S Criseno, N Karavitaki Pituitary Tumors, 679-685, 2021 | 2 | 2021 |
| UK Practice on incidentally detected non-functioning pituitary microadenomas: analysis of two national surveys during a 12-year interval R Hamblin, A Fountas, M Levy, N Karavitaki Pituitary 26 (1), 94-104, 2023 | 1 | 2023 |
| Long-term outcomes of non-operated non-functioning pituitary macroadenomas-results from the UK NFPA consortium A Fountas, K Lithgow, LP Benjamin, E Bonanos, SS Khalid, K Mitchell, ... Endocrine Abstracts 94, 2023 | | 2023 |
| Natural history of non-functioning pituitary microadenomas-results from the UK NFA consortium R Hamblin, A Fountas, K Lithgow, PB Loughrey, E Bonanos, SS Khalid, ... Endocrine Abstracts 86, 2022 | | 2022 |
| A TSH-secreting pituitary adenoma cured from SSA monotherapy alone: Disease free more than three years after stopping treatment K Bhavra, R Hamblin, J Ayuk, K Boelaert, N Karavitaki Endocrine Abstracts 86, 2022 | | 2022 |
| Risk of second brain tumour after radiotherapy for pituitary adenoma or craniopharyngioma R Hamblin, A Vardon, J Akpalu, M Tampourlou, I Spiliotis, E Sbardella, ... | | 2022 |
| Radiotherapy for adults with pituitary adenoma or craniopharyngioma is associated with increased risk of second brain tumour: A multi-centre study of 3,613 patients with long … R Hamblin, A Vardon, J Akpalu, M Tampourlou, I Spiliotis, E Sbardella, ... Endocrine Abstracts 81, 2022 | | 2022 |
| UK practice on incidentally detected non-functioning pituitary microadenomas R Hamblin, A Fountas, MJ Levy, N Karavitaki | | 2022 |
| Cardiovascular health and mortality in Cushing’s A Coulden, R Hamblin, J Wass, N Karavitaki | | 2022 |
| Is radiotherapy for pituitary adenoma or craniopharyngioma associated with increased risk of second brain tumour? A long-term multi-centre study of 3,679 patients R Hamblin, A Vardon, J Akpalu, M Tampourlou, I Spiliotis, E Sbardella, ... Endocrine Abstracts 77, 2021 | | 2021 |
| Biochemical screening of adrenal incidentalomas may lead to early detection of MEN2A R Hamblin, H Gleeson, M Levy Endocrine Abstracts 28, 2012 | | 2012 |
| Addison's disease: An endocrine emergency R Hamblin, M Haq, D Barnes | | |
| PATHOLOGY AND PATHOGENESIS K Lithgow, R Hamblin, N Karavitaki | | |
